Navigation Links
Regado Biosciences Establishes Medical Advisory Board
Date:6/2/2009

diology, University of Alberta, Edmonton, Alberta, Canada and Director of the Canadian VIGOUR Centre (Virtual Coordinating Centre for Global Collaborative Cardiovascular Research)
  • Richard C. Becker, MD, Professor of Medicine and Director of the Cardiovascular Thrombosis Center, Duke Clinical Research Institute, Duke University, Durham, North Carolina
  • Robert M. Califf, MD, (Special Advisor to Regado Biosciences, Inc. and ex officio member of the Medical Advisory Board), Vice Chancellor for Clinical Research and Professor of Medicine, Division of Cardiology, Duke University Medical Center and Director, Duke Translational Medicine Institute, Duke University, Durham, North Carolina
  • Michael Gibson, MD, Associate Professor of Medicine and Chief, Clinical Research, Cardiovascular Division, Beth Israel Deaconess Medical Center, Harvard Medical School, Harvard University, Boston, Massachusetts
  • Neal S. Kleiman, MD, Medical Director, Cardiac Catheterization Laboratories, The Methodist DeBakey Heart Center, The Methodist Hospital, Houston, Texas and Professor of Medicine, Weill Medical College, Cornell University
  • A. Michael Lincoff, MD, Director, Cleveland Clinic Coordinating Center for Clinical Research (C5Research); Director, Center for Clinical Research and Vice Chairman, Lerner Research Institute and Vice Chairman, Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio
  • Roxana Mehran, MD, Joint Chief Scientific Officer, Clinical Trial Center, Cardiovascular Research Foundation, New York, New York and Associate Professor of Medicine, Columbia University Medical Center, Columbia University, New York, New York
  • Harvey White, DSc, Honorary Clinical Professor of Medicine, University of Auckland and Dir
    '/>"/>

  • SOURCE Regado Biosciences, Inc.
    Copyright©2009 PR Newswire.
    All rights reserved

    Page: 1 2 3

    Related biology technology :

    1. Regado Biosciences REG1 Anticoagulation System Study Results Published in the Journal of Thrombosis and Haemostasis
    2. David J. Mazzo, Ph.D., Joins Regado Biosciences as President and CEO
    3. Regado Biosciences to Present at the Piper Jaffray Health Care Conference on Tuesday, December 2, 2008
    4. Ellen McDonald Joins Regado Biosciences as Senior Vice President of Business Operations and Chief Business Officer
    5. Regado Biosciences To Present at the 27th Annual J.P. Morgan Healthcare Conference
    6. Dr. Steven L. Zelenkofske Joins Regado Biosciences as Senior Vice President, Clinical and Medical Affairs and Chief Medical Officer
    7. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
    8. Selection of Development Candidate Triggers $0.5 Million Milestone Payment to Ardea Biosciences, Inc.
    9. ImmuneRegen BioSciences Files 8-K that Highlights Enclosed Shareholder Letter Discussing Recent Achievements and Outlook
    10. ONCOSCIENCE AG, THE EUROPEAN PARTNER OF YM BIOSCIENCES, ANNOUNCES COMPLETION OF PATIENT ENROLLMENT IN PHASE III BRAIN CANCER TRIAL OF NIMOTUZUMAB
    11. Pressure BioSciences, Inc. Reports Second Quarter 2007 Financial Results and Provides Business Update
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:12/24/2014)... 2014 Sigma-Aldrich Corporation (NASDAQ: ... under the Hart-Scott-Rodino Antitrust Improvements Act (HSR Act) ... 22, 2014, thereby completing the U.S. HSR Act ... of the Company by Merck KGaA, Darmstadt, Germany.  ... condition to closing the transaction, which remains subject ...
    (Date:12/22/2014)... - RepliCel Life Sciences Inc. (OTCQB: REPCF) (TSX.V: RP), ... development of autologous cell therapies, announced today the publication ... in conjunction with co-authors from Kyoto University and the ... ongoing clinical research using dermal sheath cup (DSC) cells ... The paper entitled " Hair Follicle Dermal Stem Cells ...
    (Date:12/22/2014)... ITRA Global, one of the largest organizations ... estate, has further expanded its global reach with the ... Western Australia, reports Mylinda Vick, CCIM, Chairman of the ... / ACORPP (Australian Corporate Property and Projects) , is ... services to a wide range of clients in the ...
    (Date:12/19/2014)... Naurex Inc., a biopharmaceutical company leveraging its ... the central nervous system, today announced that Norbert ... present at the 33 rd annual J.P. Morgan ... 3:00 p.m. PST on Tuesday, January 13, 2015, at ... Calif. About Naurex Inc. ...
    Breaking Biology Technology:Acquisition of Sigma-Aldrich by Merck KGaA, Darmstadt, Germany, Receives U.S. Antitrust Clearance 2Acquisition of Sigma-Aldrich by Merck KGaA, Darmstadt, Germany, Receives U.S. Antitrust Clearance 3Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 2Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 3Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 4Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 5ITRA Global Continues International Expansion in Perth and Brisbane, Australia 2Naurex to Present at 33rd Annual J.P. Morgan Healthcare Conference 2
    ... - BioSyntech, Inc. (TSX: BSY), a biotechnology company ... statistically significant results from an analysis of patients ... BST-CarGel(R) randomized clinical trial. Specifically, statistically significant evidence ... treatment was found during analyses of tissues biopsied ...
    ... CommNexus ... , ... CA (PRWEB) June 17, 2009 -- CommNexus and Leap Wireless, International, Inc., ... today announce their support for EvoNexus, a non-profit incubator dedicated to helping San Diego ...
    ... , SAN JOSE, Calif., June 17 Oclaro, Inc. ... of its 200,000th Fluorescence Filter for biomedical and analytical ... in a wide range of biomedical and analytical applications, ... and disease detection. The latest offerings from the Oclaro ...
    Cached Biology Technology:BioSyntech Reports Positive Results from Pivotal Trial for BST-CarGel(R) Cartilage Repair Device 2BioSyntech Reports Positive Results from Pivotal Trial for BST-CarGel(R) Cartilage Repair Device 3BioSyntech Reports Positive Results from Pivotal Trial for BST-CarGel(R) Cartilage Repair Device 4BioSyntech Reports Positive Results from Pivotal Trial for BST-CarGel(R) Cartilage Repair Device 5San Diego Wireless Heavyweight Leap Wireless Supports New Start-up Incubator 2San Diego Wireless Heavyweight Leap Wireless Supports New Start-up Incubator 3San Diego Wireless Heavyweight Leap Wireless Supports New Start-up Incubator 4Oclaro(TM) Hits Milestone With Clarity(TM) Fluorescence Filters 2Oclaro(TM) Hits Milestone With Clarity(TM) Fluorescence Filters 3
    (Date:12/3/2014)... , Dec. 2, 2014   Marvin Test ... innovative test solutions for military, aerospace, and manufacturing ... of its successful TS-900 PXI semiconductor test ... features of high-end systems to customers at a ... compared to traditional ATE. "Our ...
    (Date:11/21/2014)... , Nov. 19, 2014  Earlier this year ... York College, and one of the most prolific inventors ... that are transmitted from Smartphones to third party agencies. ... and has one of the earliest known patents in ... usage in the military, child care, elder care and ...
    (Date:11/21/2014)... JOSE, Calif. , Nov. 20, 2014   ... global leader in microcontroller (MCU) and touch technology solutions, ... digital temperature sensors with the widest V cc ... delivers higher temperature accuracy and faster I 2 C ... registers and serial EEPROM memory making them ideal for ...
    Breaking Biology News(10 mins):Marvin Test Solutions Brings New Capabilities to PXI-Based Semiconductor Test with TS-960 2Marvin Test Solutions Brings New Capabilities to PXI-Based Semiconductor Test with TS-960 3Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 2Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 3Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 4Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 2Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 3Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 4
    ... to Research Careers) Program has announced the travel award ... (SLB) Meeting in Vancouver, British Columbia, Canada from October ... the entry of underrepresented minority students, postdoctorates and scientists ... to encourage the participation of young scientists at the ...
    ... led by St. Jude Children,s Research Hospital investigators adds to ... the developing brain and visual system, safeguarding the future retina ... of a signaling protein capable of disrupting the process. ... developing nervous system as a key regulator of the Wnt ...
    ... have found that a key protein that regulates the ... the liver and that altering the levels of this ... Their discovery, detailed in this week,s advanced online publication ... entirely new biochemical approach for scientists to develop treatments ...
    Cached Biology News:Scientists show Six3 gene essential for retinal development 2Biologists discover biochemical link between biological clock and diabetes 2Biologists discover biochemical link between biological clock and diabetes 3Biologists discover biochemical link between biological clock and diabetes 4
    PlusOne EDTA, disodium salt, 100 g. Category: Electrophoresis Systems & Standards & Reagents, Electrophoresis Standards and Reagents, Buffers....
    Human/Mouse/Rat p38 alpha Affinity Purified PAb...
    XBP1 Antibody...
    Recombinant Mouse LIGHT/TNFSF14...
    Biology Products: